Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. ELAB
stocks logo

ELAB

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for PMGC Holdings Inc (ELAB.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess PMGC Holdings Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ELAB News & Events

Events Timeline

(ET)
2025-10-30
08:12:11
PMGC Confirms ITAR Registration Approval for AGA Precision Systems
select
2025-10-28 (ET)
2025-10-28
08:20:31
PMGC Subsidiary Purchases All Operational Assets of Indarg Engineering
select
2025-10-20 (ET)
2025-10-20
07:37:09
PMGC Reveals Sales Backlog Exceeding $711,000 at AGA Precision Systems
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.0
09-04Newsfilter
Northstrive Biosciences Completes Phase II of AI Development Program with YuvaBio, Utilizing MitoNova™ AI Platform to Create Therapies for Obesity and Cardiometabolic Conditions
  • Collaboration Announcement: Northstrive Biosciences and Yuva Biosciences have completed Phase II of their AI Development Program, focusing on using YuvaBio's MitoNova™ platform to identify small molecule candidates aimed at improving mitochondrial health for treating obesity and cardiometabolic conditions.

  • Candidate Selection: YuvaBio has provided Northstrive with a shortlist of compounds derived from 12 curated libraries, which are intended for biological validation and potential advancement to experimental testing and clinical development.

[object Object]
Preview
2.0
09-01TipRanks
Stock Splits Scheduled for This Week (September 2 to September 5) – Keep Your Investments Active

Upcoming Stock Splits (September 2 - September 5)

  • Overview of Stock Splits: Stock splits are a common practice in the financial market where companies increase the number of shares available without altering the overall market value. This typically results in a lower share price, making stocks more accessible to retail investors. Conversely, reverse stock splits consolidate shares, increasing the price per share to meet listing requirements or avoid delisting.

Companies Announcing Stock Splits

  • MSP Recovery (MSPR): Operating as LifeWallet, MSP Recovery announced a 1-for-7 reverse stock split effective September 1, aimed at increasing its share price to comply with Nasdaq’s $1.00 minimum bid rule after facing pressure for several months.

  • PMGC Holdings (ELAB): This diversified holding company revealed a 1-for-3.5 reverse stock split effective September 2, intended to enhance market stability and attract more investors.

  • FiscalNote Holdings (NOTE): The company, which provides AI-driven data platforms, executed a 1-for-12 reverse stock split on August 29 to align its stock price with NYSE listing standards after trading below $1 for an extended period.

  • TNF Pharmaceuticals (TNFA): A clinical-stage biotech firm, TNF Pharmaceuticals approved a 1-for-100 reverse stock split to improve its share structure and comply with Nasdaq’s minimum bid rule, effective September 2.

  • Lucid Group (LCID): Known for its luxury electric vehicles, Lucid Group announced a 1-for-10 reverse stock split effective August 29, aimed at boosting its share price and maintaining compliance with Nasdaq listing standards.

  • CNFinance Holdings (CNF): This Chinese financial services provider will implement a 1-for-10 reverse ADS split, changing its ADS ratio from 1:20 to 1:200 Class A shares, effective September 5, to enhance its per-share price and uphold its NYSE listing.

Conclusion

  • Market Implications: These stock splits and reverse splits are strategic moves by companies to either attract new investors or ensure compliance with exchange listing requirements, reflecting their ongoing efforts to stabilize and enhance market perception. For further details on historical and upcoming stock splits, the TipRanks Stock Splits Calendar can be consulted.
[object Object]
Preview
4.5
08-22Benzinga
Dow Rises More Than 300 Points; BJ's Wholesale Stock Declines Following Q2 Earnings Report
  • U.S. Stock Market Performance: U.S. stocks rose this morning, with the Dow Jones increasing by over 300 points, closing at 45,109.99, while NASDAQ and S&P 500 also saw gains.

  • Sector Movements: Communication services shares increased by 0.9%, and information technology stocks rose by 0.2% on Friday.

  • Company Earnings Reports: BJ's Wholesale Club shares fell 7% after missing revenue expectations despite beating earnings per share estimates; meanwhile, EpicQuest Education Group's shares surged 176% due to strong financial results.

  • Global Market Trends: European shares were up, with the eurozone's STOXX 600 gaining 0.4%, while Asian markets closed mixed, with Japan's Nikkei slightly up and India's BSE Sensex down 0.85%.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is PMGC Holdings Inc (ELAB) stock price today?

The current price of ELAB is 4.98 USD — it has decreased -2.73 % in the last trading day.

arrow icon

What is PMGC Holdings Inc (ELAB)'s business?

PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. The Company's portfolio consists of various subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., PMGC Capital LLC, and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. AGA Precision Systems LLC specializes in CNC machining operations.

arrow icon

What is the price predicton of ELAB Stock?

Wall Street analysts forecast ELAB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELAB is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is PMGC Holdings Inc (ELAB)'s revenue for the last quarter?

PMGC Holdings Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

arrow icon

What is PMGC Holdings Inc (ELAB)'s earnings per share (EPS) for the last quarter?

PMGC Holdings Inc. EPS for the last quarter amounts to -0.45 USD, decreased -99.58 % YoY.

arrow icon

What changes have occurred in the market's expectations for PMGC Holdings Inc (ELAB)'s fundamentals?

The market is revising No Change the revenue expectations for ELAB for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 9.93%.
arrow icon

How many employees does PMGC Holdings Inc (ELAB). have?

PMGC Holdings Inc (ELAB) has 2 emplpoyees as of December 05 2025.

arrow icon

What is PMGC Holdings Inc (ELAB) market cap?

Today ELAB has the market capitalization of 3.71M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free